Amgen breaks ground on new biomanufacturing facility in Ohio, US
The new manufacturing facility will feature advanced technologies and sustainability advancements, to produce medicines for the US
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Nov 21
The new manufacturing facility will feature advanced technologies and sustainability advancements, to produce medicines for the US
22 Oct 21
The agreement extends Novartis’ earlier supply agreement for the fill and finish of more than 50 million doses…
08 Oct 21
The new facility includes drug substance manufacturing along with fill/finish and packaging
16 Sep 21
The country is focusing more on building expertise in mRNA vaccines and viral vector shots
08 Sep 21
Masterflex Bioprocessing provides peristaltic and single-use bioprocessing solutions and aseptic single-use fluid transfer technologies
06 Sep 21
AstraZeneca will deliver 60 million doses by the end of Q3 2021, 75 million doses by the end…
11 Aug 21
The new manufacturing facility will support Canada with direct access to domestically manufactured vaccines against respiratory viruses
19 Jul 21
The company aims to secure up to £400m in new private investment and create up to 5,000 new…
16 Jul 21
The new drug is currently being tested in a Phase 3 clinical trial in Kenya and Côte d’Ivoire
16 Jul 21
The company will expand its research and development capabilities in the Tarrytown campus